GIULIANI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 9.738
EU - Europa 3.505
AS - Asia 908
SA - Sud America 13
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 14.183
Nazione #
US - Stati Uniti d'America 9.704
GB - Regno Unito 1.547
SE - Svezia 479
IT - Italia 427
CN - Cina 344
DE - Germania 299
UA - Ucraina 264
HK - Hong Kong 241
TR - Turchia 228
FI - Finlandia 175
FR - Francia 104
BG - Bulgaria 100
CA - Canada 31
BE - Belgio 24
IE - Irlanda 24
IN - India 19
NL - Olanda 15
RU - Federazione Russa 14
AU - Australia 10
IR - Iran 10
JP - Giappone 10
MY - Malesia 9
PH - Filippine 9
SG - Singapore 9
ES - Italia 8
BR - Brasile 7
VN - Vietnam 7
EU - Europa 6
CZ - Repubblica Ceca 5
PK - Pakistan 5
CL - Cile 4
HU - Ungheria 4
KR - Corea 4
RO - Romania 4
CH - Svizzera 3
ID - Indonesia 3
NO - Norvegia 3
TW - Taiwan 3
IL - Israele 2
MX - Messico 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
BO - Bolivia 1
BZ - Belize 1
EE - Estonia 1
GR - Grecia 1
IS - Islanda 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
SA - Arabia Saudita 1
Totale 14.183
Città #
Fairfield 1.500
Southend 1.276
Woodbridge 860
Ashburn 825
Chandler 795
Houston 786
Jacksonville 604
Seattle 556
Ann Arbor 526
Cambridge 502
Wilmington 454
Dearborn 415
Nyköping 325
Hong Kong 238
Modena 148
Izmir 137
Beijing 121
San Diego 119
Princeton 108
Eugene 100
Sofia 99
Des Moines 84
Helsinki 80
Redwood City 55
Shanghai 48
New York 46
London 36
Bremen 35
Milan 33
Falls Church 32
Norwalk 27
Dublin 24
Brussels 23
Boardman 20
Hefei 18
Fremont 16
Kilburn 16
Kunming 15
Hounslow 14
Bologna 12
Toronto 12
Ottawa 11
Verona 11
Renton 10
Rome 10
Shenyang 10
Chiswick 9
Leawood 8
Phoenix 8
Prescot 8
Guangzhou 7
Las Vegas 7
Mountain View 7
Nanjing 7
Dong Ket 6
Los Angeles 6
Napoli 6
Parma 6
Augusta 5
Dongguan 5
Grafing 5
Islamabad 5
Jinan 5
Liberty 5
Piadena 5
Reggio Emilia 5
San Giuliano Milanese 5
San Jose 5
San Mateo 5
Strasbourg 5
Sydney 5
Tulare 5
Uludag 5
Albuquerque 4
Auburn Hills 4
Chicago 4
East Rutherford 4
Formigine 4
Fuzhou 4
Hebei 4
Indiana 4
Islington 4
Mumbai 4
Nanchang 4
São Paulo 4
Urbino 4
Wenzhou 4
Brescia 3
Chengdu 3
Detroit 3
Flensburg 3
Hangzhou 3
Issy-les-moulineaux 3
Monmouth Junction 3
Montréal 3
Mykolayiv 3
Nyíregyháza 3
Saint Louis 3
Saint Petersburg 3
Serra 3
Totale 11.447
Nome #
Mechanisms of Hydrogen Sulfide against the Progression of Severe Alzheimer’s Disease in Transgenic Mice at Different Ages 285
Regenerative potential of human dental pulp stem cells in the treatment of stress urinary incontinence: In vitro and in vivo study 247
NDP-α-MSH induces intense neurogenesis and cognitive recovery in Alzheimer transgenic mice through activation of melanocortin MC4 receptors 243
Up-regulation of the canonical Wnt-3A and Sonic hedgehog signaling underlies melanocortin-induced neurogenesis after cerebral ischemia 215
NDP-α-MSH attenuates heart and liver responses to myocardial reperfusion via the vagus nerve and JAK/ERK/STAT signaling 207
Effects of COX1-2/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice 205
Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy. 205
Multiple beneficial effects of melanocortin MC4 receptor agonists in experimental neurodegenerative disorders: Therapeutic perspectives 199
Effects of ketamine anesthesia on central nociceptive processing in the rat: a 2-deoxyglucose study. 199
Melanocortins protect against multiple organ dysfunction syndrome in mice 180
Independent time courses of supraspinal nociceptive activity and spinally mediated behavior during tonic pain 180
Melanocortins and the cholinergic anti-inflammatory pathway. 179
Effects of aglycone genistein in a rat experimental model of postmenopausal metabolic syndrome. 177
Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia 177
Melanocortins counteract inflammatory and apoptotic responses to prolonged myocardial ischemia/reperfusion through a vagus nerve-mediated mechanism 177
Effect of sumatriptan in different models of pain in rats 177
Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats 174
Melanocortin MC(4) receptor agonists counteract late inflammatory and apoptotic responses and improve neuronal functionality after cerebral ischemia. 173
Vagus nerve mediates the protective effects of melanocortins against cerebral and systemic damage after ischemic stroke. 172
Melanocortin 4 receptor activation protects against testicular ischemia-reperfusion injury by triggering the cholinergic antiinflammatory pathway. 172
Melanocortin 4 receptor stimulation decreases pancreatitis severity in rats by activation of the cholinergic anti-inflammatory pathway 172
CNS pattern of metabolic activity during tonic pain: evidence for modulation by beta-endorphin 171
Treatment of cerebral ischemia with melanocortins acting at MC(4) receptors induces marked neurogenesis and long-lasting functional recovery. 170
Neuroprotection in focal cerebral ischemia owing to delayed treatment with melanocortins. 167
Centrally acting leptin induces a resuscitating effect in haemorrhagic shock in rats. 167
Functional recovery after delayed treatment of ischemic stroke with melanocortins is associated with overexpression of the activity-dependent gene Zif268 166
Melanocortins protect against progression of Alzheimer's disease in triple-transgenic mice by targeting multiple pathophysiological pathways 165
B-HT 920-INDUCED EFFECTS ON RAT FEEDING BEHAVIOUR 165
A COMPARATIVE-STUDY OF B-HT 920 AND DIAZEPAM IN THE X-MAZE FEEDING TEST 164
Modulation of the JAK/ERK/STAT signaling in melanocortin-induced inhibition of local and systemic responses to myocardial ischemia/reperfusion 163
Cannabimimetic activity in rats and pigeons of HU 210, a potent antiemetic drug 162
Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage 162
Molecular Changes Induced in Rat Liver by Hemorrhage and Effects of Melanocortin Treatment. 157
Influence of sildenafil on copulatory behaviour in sluggish or normal ejaculator male rats: a central dopamine mediated effect? 156
THE CANNABINOID AGONIST HU 210 MODIFIES RAT BEHAVIOURAL RESPONSES TO NOVELTY AND STRESS 154
Sexual attraction and copulation in male rats: effects of the dopamine agonist SND 919 152
Modulatory activity of sildenafil on copulatory behaviour of both intact and castrated male rats 152
Protective effects of melanocortins on short-term changes in a rat model of traumatic brain injury 152
Efferent vagal fibre stimulation blunts nuclear factor-kappa B activation and protects against hypovolemic hemorrhagic shock 151
Behavioral effects induced by the dopamine D-3 agonist 7-OH-DPAT in sexually-active and -inactive male rats 150
THE D2 AGONIST B-HT 920 POTENTLY ANTAGONIZES RAT GROOMING. 149
Melanocortins as potential therapeutic agents in severe hypoxic conditions. 149
Melanocortins protect against brain damage and counteract cognitive decline in a transgenic mouse model of moderate Alzheimer׳s disease. 149
BEHAVIOURAL EFFECTS INDUCED IN RATS AND CHICKS BY D2 DOPAMINE AGONISTS 147
BEHAVIOURAL ASSESSMENT IN RATS OF THE ANTIPSYCHOTIC POTENTIAL OF THE POTENT DOPAMINE D2 RECEPTOR ANTAGONIST, (-) ETICLOPRIDE 147
EFFECTS OF THE CANNABINOID RECEPTOR AGONIST, HU 210, ON INGESTIVE BEHAVIOUR AND BODY WEIGHT OF RATS 144
EFFECT OF THE D2-AUTORECEPTOR AGONIST B-HT-958 ON BOTH SPONTANEOUS AND ACTH-INDUCED STRETCHING, YAWNING AND GROOMING IN THE RAT 143
BEHAVIOURAL EFFECTS OF THE DOPAMINE D3 RECEPTOR AGONIST, 7-OH-DPAT IN RATS. 143
INFLUENCE OF ACTH-(1-24) ON INGESTIVE BEHAVIOURS 143
BEHAVIOURAL PROFILE IN CHICKEN OF CQ 32-084 AND CQP 201-403, TWO DOPAMINE AGONISTS 143
Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms. 143
Differential behavioral response to dopamine D-2 agonists by sexually naive, sexually active, and sexually inactive male rats 142
Recombinant human erythropoietin improves angiogenesis and wound healing in experimental burn wounds 142
Neuroleptic-like profile of the cannabinoid agonist, HU 210, on rodent behavioural models 141
Melanocortins promote neurogenesis and counteract cognitive decline in a transgenic mouse model of moderate Alzheimer’s disease 139
Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway 136
MC3 receptors are involved in the protective effect of melanocortins in myocardial ischemia/reperfusion-induced arrhythmias 134
THE SELECTIVE D-2-DOPAMINE-RECEPTOR ANTAGONIST ETICLOPRIDE COUNTERACTS THE EJACULATIO-PRAECOX INDUCED BY THE SELECTIVE D-2-DOPAMINE AGONIST SND-919 IN THE RAT 133
Influence of the cannabinoid agonist HU 210 on cocaine- and CQP 201-403-induced behavioural effects in rat 133
HU 210: A potent tool for investigations of the cannabinoid system 132
SUPPRESSIVE EFFECT OF THE DOPAMINE D2-RECEPTOR AGONIST B-HT 920 ON RAT GROOMING 131
Broad therapeutic treatment window of [Nle(4), D-Phe(7)]alpha-melanocyte-stimulating hormone for long-lasting protection against ischemic stroke, in Mongolian gerbils 131
Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC3 receptors 128
Involvement of dopamine receptors in the antipsychotic profile of )eticlopride 128
The disaccharide trehalose inhibits proinflammatory phenotype activation in macrophages and prevents mortality in experimental septic shock 128
Effects of )eticlopride and 7-OH-DPAT on the tail-suspension test in mice 127
Learning impairment produced in rats by the cannabinoid agonist HU 210 in a water-maze task 127
Azione neuroprotettiva dei peptici melanocortinici nell’ictus ischemico sperimentale 125
A COMPARATIVE BEHAVIOURAL ANALYSIS IN RATS OF THE D2 AGONIST RU 24213 AND TWO NEW STRUCTURALLY SIMILAR COMPOUNDS 124
Effect of late treatment with gamma-hydroxybutyrate on the histological and behavioral consequences of transient brain ischemia in the rat. 124
Inhibitory effects of the cannabinoid agonist HU 210 on rat sexual behaviour 123
INVOLVEMENT OF DOPAMINE D2 RECEPTORS IN THE EFFECT OF COCAINE ON SEXUAL BEHAVIOUR AND STRETCHING-YAWNING OF MALE RATS. 123
BRAIN ACETYLCHOLINE IS INVOLVED IN THE ACTH-INDUCED BEHAVIORAL SYNDROME IN RATS 123
Influence of eticlopride on cocaine- and DA D-2 agonist-induced behavioral effects in rats 122
Rat cognitive function during and after treatment with the cannabinoid agonist, HU 210 121
INABILITY OF )DEPRENYL TO MODIFY COPULATORY PERFORMANCE IN THE MALE-RAT, WHETHER OR NOT STIMULATED BY THE SELECTIVE D-2 DOPAMINE AGONIST SND-919 120
Influence of sildenafil on central dopamine-mediated behaviour in male rats 120
I neuropeptidi melanocortinici nell’approccio cardioprotettivo contro il danno da ischemia e da riperfusione 116
B-HT 920 STIMULATES FEEDING AND ANTAGONIZES ANOREXIA INDUCED BY ACTH AND IMMOBILIZATION 112
GROOMING AND STRETCHING-YAWNING - 2 BEHAVIORAL POINTERS OF D2 DOPAMINE RECEPTOR AGONISTIC EFFECT 111
INVOLVEMENT OF THE HISTAMINERGIC SYSTEM IN CENTRALLY-ACTING LEPTIN-EVOKED RESUSCITATING EFFECT IN HAEMORRHAGIC SHOCK IN RATS 110
Melanocortin receptor-4 and glioblastoma cells: effects of the selective antagonist ML00253764 alone and in combination with temozolomide on cell proliferation and apoptosis. 108
NPY-induced inhibition of male copulatory acivity is a direct behavioural effect 101
HYPERPHAGIC EFFECT OF B-HT-920 IN A MODIFIED X-MAZE TEST 99
Sull'identificazione di una via colinergica anti-shock fisiologica e dipendente dalle melanocortine. 98
Involvement of the histaminergic system in the resuscitating effect of centrally acting leptin in haemorrhagic shock in rats 97
Oxidative stress in Alzheimer's disease: In vitro therapeutic effect of amniotic fluid stem cells extracellular vesicles 96
Synthesis, resolution, and preliminary evaluation of trans-2-amino-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes and related derivatives as dopamine receptors ligands 94
Involvement of the brain histaminergic system in the melanocortin MC4 receptor agonist RO27-3225-induced resuscitating effect in haemorrhage-shocked rats – haemodynamic studies. 94
Effect of the cannabinoid receptor agonist, HU 210, on body weight and feeding behaviour of rats 93
INFLUENCE OF IDAZOXAN ON THE DOPAMINE D(2) RECEPTOR AGONIST-INDUCED BEHAVIORAL-EFFECTS IN RATS 93
Melanocortins protect against myocardial ischemia/reperfusion injury through the activation of an efferent cholinergic pathway 89
EFFECT ON RAT-FEEDING BEHAVIOR OF 2 SELECTIVE D-2-DOPAMINE AGONISTS 88
Activation of the cholinergic anti-inflammatory pathway reduces NF-kappa B activation, blunts TNF-alpha production, and protects against splanchnic artery occlusion shock 88
Protective effects of the melanocortin analog NDP-α-MSH in rats undergoing cardiac arrest 87
Neuroprotection against ischemic stroke by early or delayed treatment with MC4 receptor-stimulating melanocortins 84
EFFECTS OF THE DOPAMINE D(2)-AGONISTS LISURIDE AND CQ 32-084 ON RAT-FEEDING BEHAVIOR 79
BEHAVIORAL EVIDENCE THAT DIFFERENT NEUROCHEMICAL MECHANISMS UNDERLY STRETCHING-YAWNING AND PENILE ERECTION INDUCED IN MALE-RATS BY SND-919, A NEW SELECTIVE D-2 DOPAMINE-RECEPTOR AGONIST 78
Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer’s Disease 54
Erratum: Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC3 receptors (European Journal of Pharmacology (2003) 477 (227-234)) 52
Totale 14.239
Categoria #
all - tutte 57.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.299


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.124 0 0 0 0 0 0 0 0 0 207 410 507
2019/20203.349 213 228 158 259 324 502 611 306 326 103 161 158
2020/20212.442 201 167 232 267 261 119 190 303 89 329 162 122
2021/20222.117 38 297 267 103 36 71 152 91 196 126 501 239
2022/20232.075 239 237 155 215 198 365 25 189 265 14 71 102
2023/20241.054 43 89 86 108 253 109 115 191 35 25 0 0
Totale 14.369